Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
India Launches Anti-Dumping Campaign Against Chinese Vitamin B12 and Ceftriaxone Sodium Producers
November 23, 2024
Company
Novartis Sees 15% Global Sales Growth and Significant Investment in China for 2006
November 23, 2024
Hospital
R&D
Ruijin Hospital Researchers Uncover Five New Mutations in Rare 17OHD Endocrine Disorder
November 23, 2024
Policy / Regulatory
China’s SFDA Mandates Official Position Rotation to Boost Transparency
November 23, 2024
Policy / Regulatory
Guangdong’s ‘Sunlight Purchase’ System Sparks Drug Pricing War and Uncovers Pricing Anomalies
November 23, 2024
Hospital
R&D
Ruijin Hospital Unveils Five New Mutations in Rare Adrenal Hyperplasia Study
November 23, 2024
Policy / Regulatory
SFDA Embraces Transparency: Regular Press Briefings and Personnel Rotations Announced
November 23, 2024
Company
China’s Western Pharmaceutical Exports Soar 23% in 2006, Led by Antibiotics
November 23, 2024
Drug
Medical Device
Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China
November 23, 2024
1
2
…
1,199
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?